Nanotechnology could soon help oncologists spot the tiny breakaway cells that grow into potentially lethal metastatic tumours, "mets", in breast and other forms of cancer. Chain-like clusters of nanoparticles can sweep through blood vessels and latch on to any metastatic cells in the lining of blood vessels before these grow to untreatable sizes.
Fluorescence molecular tomography and magnetic resonance imaging (MRI) will allow oncologists and radiographers to see precisely where the mets are in the blood vessels and treat them before they start growing into tumours or reach vulnerable organs such as the liver and lungs.
Detecting mets to boost cancer survivability.
(10.1364/BOE.3.00263636)



About